Arrhythmogenic right ventricular cardiomyopathy (ARVC) Circulatory System Arrhythmogenic right ventricular cardiomyopathy (ARVC)
Conditions
Interventions
Participants (both healthy controls and those with ARVC) undergo a cardiac magnetic resonance imaging (CMR). This is done for participants as part of their clinical workup for an ARVC diagnosis (accor
Sponsors
Linköping University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients: 1. Diagnosis of a definite ARVC 2. Have not received an implantable cardioverter defibrillator (ICD) 3. Aged 18 years and older Healthy Participants: 1. Age matched asymptomatic who lack a family history of premature cardiovascular disease 2. Not on cardiac medication 3. Pass a cardiac exercise test 4. Aged 18 years and older
Exclusion criteria
Exclusion criteria: The presence of an implantable cardioverter defibrillator (ICD).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Strain values are measured using Feature tracking method once with clinically indicated CMR with additional acquisition model at baseline 2. Time to peak strain is measured using the Feature tracking method with clinically indicated CMR with additional acquisition model at baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Arrhythmia relation to strain values are measuring using the CMR examination with additional acquisition and the yearly interrogation of ICDs and available Holter recordings at year one, two, three, four and five (or when clinically necessary) | — |
Countries
Sweden
Outcome results
None listed